GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Karolinska Development AB (LTS:0P3C) » Definitions » Cyclically Adjusted PB Ratio

Karolinska Development AB (LTS:0P3C) Cyclically Adjusted PB Ratio : 0.21 (As of Sep. 21, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Karolinska Development AB Cyclically Adjusted PB Ratio?

As of today (2024-09-21), Karolinska Development AB's current share price is kr1.54375. Karolinska Development AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was kr7.22. Karolinska Development AB's Cyclically Adjusted PB Ratio for today is 0.21.

The historical rank and industry rank for Karolinska Development AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

LTS:0P3C' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.09   Med: 0.16   Max: 0.46
Current: 0.19

During the past years, Karolinska Development AB's highest Cyclically Adjusted PB Ratio was 0.46. The lowest was 0.09. And the median was 0.16.

LTS:0P3C's Cyclically Adjusted PB Ratio is ranked better than
82.67% of 606 companies
in the Biotechnology industry
Industry Median: 1.605 vs LTS:0P3C: 0.19

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Karolinska Development AB's adjusted book value per share data for the three months ended in Jun. 2024 was kr4.562. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr7.22 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Karolinska Development AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Karolinska Development AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karolinska Development AB Cyclically Adjusted PB Ratio Chart

Karolinska Development AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.10 0.33 0.14 0.20

Karolinska Development AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.17 0.20 0.20 0.21

Competitive Comparison of Karolinska Development AB's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Karolinska Development AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Karolinska Development AB's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Karolinska Development AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Karolinska Development AB's Cyclically Adjusted PB Ratio falls into.



Karolinska Development AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Karolinska Development AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.54375/7.22
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Karolinska Development AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Karolinska Development AB's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=4.562/132.7160*132.7160
=4.562

Current CPI (Jun. 2024) = 132.7160.

Karolinska Development AB Quarterly Data

Book Value per Share CPI Adj_Book
201409 27.027 100.161 35.812
201412 20.944 100.225 27.734
201503 23.603 99.950 31.341
201506 6.615 99.995 8.780
201509 6.153 100.228 8.147
201512 4.126 100.276 5.461
201603 2.468 100.751 3.251
201606 1.328 101.019 1.745
201609 0.993 101.138 1.303
201612 0.496 102.022 0.645
201703 1.180 102.022 1.535
201706 0.643 102.752 0.831
201709 3.667 103.279 4.712
201712 3.689 103.793 4.717
201803 3.404 103.962 4.345
201806 3.823 104.875 4.838
201809 3.907 105.679 4.907
201812 4.085 105.912 5.119
201903 3.828 105.886 4.798
201906 3.931 106.742 4.888
201909 3.729 107.214 4.616
201912 5.087 107.766 6.265
202003 4.450 106.563 5.542
202006 4.461 107.498 5.508
202009 3.606 107.635 4.446
202012 4.040 108.296 4.951
202103 3.914 108.360 4.794
202106 5.007 108.928 6.100
202109 5.001 110.338 6.015
202112 4.902 112.486 5.784
202203 4.818 114.825 5.569
202206 4.736 118.384 5.309
202209 4.564 122.296 4.953
202212 4.601 126.365 4.832
202303 4.497 127.042 4.698
202306 4.583 129.407 4.700
202309 4.628 130.224 4.717
202312 4.621 131.912 4.649
202403 4.621 132.205 4.639
202406 4.562 132.716 4.562

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Karolinska Development AB  (LTS:0P3C) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Karolinska Development AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Karolinska Development AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Karolinska Development AB Business Description

Traded in Other Exchanges
Address
TomtebodavAgen 23 A, Solna, SWE, SE-171 65
Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; Umecrine Cognition; and OssDsign.

Karolinska Development AB Headlines

No Headlines